Sedation Of Adult Patients Undergoing Gastrointestinal Endoscopy: A Network Meta-analysis

NCT03632330 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6963

Last updated 2023-04-06

No results posted yet for this study

Summary

The objective of this study is to compare the efficacy and safety of dexmedetomidine with other sedatives in sedation during endoscopy by analyzing the most recently published interventional trials and observational studies.

Conditions

  • Gastrointestinal Endoscopy
  • Sedation
  • Dexmedetomidine

Interventions

DRUG

Dexmedetomidine

Dexmedetomidine group

DRUG

Midazolam

Midazolam group

DRUG

Propofol

Propofol group

DRUG

Midazolam/Propofol

Midazolam/Propofol group

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-05
Primary Completion
2018-03-07
Completion
2018-03-07

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03632330 on ClinicalTrials.gov